Mesenchymal stem cell-derived extracellular vesicles: a regulator and carrier for targeting bone-related diseases
Authors:
Top Cited Papers
Open Access
- 2 May 2024
- journal article
- review article
- Published by Springer Nature in Cell Death Discovery
- Vol. 10 (1) , 1-14
Abstract
The escalating threat of bone-related diseases poses a significant challenge to human health. Mesenchymal stem cell (MSC)-derived extracellular vesicles (MSC-EVs), as inherent cell-secreted natural products, have emerged as promising treatments for bone-related diseases. Leveraging outstanding features such as high biocompatibility, low immunogenicity, superior biological barrier penetration, and extended circulating half-life, MSC-EVs serve as potent carriers for microRNAs (miRNAs), long no-code RNAs (lncRNAs), and other biomolecules. These cargo molecules play pivotal roles in orchestrating bone metabolism and vascularity through diverse mechanisms, thereby contributing to the amelioration of bone diseases. Additionally, engineering modifications enhance the bone-targeting ability of MSC-EVs, mitigating systemic side effects and bolstering their clinical translational potential. This review comprehensively explores the mechanisms through which MSC-EVs regulate bone-related disease progression. It delves into the therapeutic potential of MSC-EVs as adept drug carriers, augmented by engineered modification strategies tailored for osteoarthritis (OA), rheumatoid arthritis (RA), osteoporosis, and osteosarcoma. In conclusion, the exceptional promise exhibited by MSC-EVs positions them as an excellent solution with considerable translational applications in clinical orthopedics.Keywords
This publication has 176 references indexed in Scilit:
- Bone‐Targeted Exosomes: Strategies and ApplicationsAdvanced Healthcare Materials, 2023
- Treatment with Mesenchymal Stem Cell‐Derived Nanovesicle‐Containing Gelatin Methacryloyl Hydrogels Alleviates Osteoarthritis by Modulating Chondrogenesis and Macrophage PolarizationAdvanced Healthcare Materials, 2023
- What Is Rheumatoid Arthritis?JAMA, 2022
- Designer Extracellular Vesicles Modulate Pro‐Neuronal Cell Responses and Improve Intracranial RetentionAdvanced Healthcare Materials, 2022
- Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery ApplicationsSmall, 2021
- Bone Vasculature and Bone Marrow Vascular Niches in Health and DiseaseJournal of Bone and Mineral Research, 2020
- VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healingJournal of Orthopaedic Research, 2018
- The extracellular vesicles‐derived from mesenchymal stromal cells: A new therapeutic option in regenerative medicineJournal of Cellular Biochemistry, 2018
- The Gasdermin‐D pore acts as a conduit for IL‐1β secretion in miceEuropean Journal of Immunology, 2017
- Exosomes secreted from mutant‐HIF‐1α‐modified bone‐marrow‐derived mesenchymal stem cells attenuate early steroid‐induced avascular necrosis of femoral head in rabbitCell Biology International, 2017